PervasID CEO & Founder Receives Silver Medal from The Royal Academy of Engineering

By AIT News Desk On Jul 5, 2021

PervasID, the company developing best-in-class battery-free Radio Frequency IDentification (RFID) reader systems for automating inventory and asset tracking, announced that its founder and CEO, Dr Sabesan Sithamparanathan, has been honoured with a Silver Medal from The Royal Academy of Engineering. The Silver Medal recognises an outstanding and demonstrated personal contribution to UK engineering, which results in successful market exploitation, by an engineer with less than 22 years in full-time employment.

Dr Sabesan has previously won a Royal Academy of Engineering Engineers Trust Young Engineer of the Year award, the Sir George Macfarlane Medal 2016 for excellence in the early stage of his career, an Engineering Enterprise Fellowship and most recently in 2021 was awarded a Queen’s Award for Enterprise: Innovation.

“Knowing where assets are located is a critical requirement for organisations of all sizes across a huge range of industries and sectors. Our Cambridge-developed battery-free RFID technology allows enterprises of all types to keep track of their inventory and asset cost effectively with unparalleled accuracy and speed,” said Dr. Sabesan Sithamparanathan, Founder & CEO of PervasID. “I am delighted and honoured to have received this prestigious award and would like to thank the Royal Academy of Engineering, which really is a recognition of the outstanding work being done by the whole team at PervasID and who are all playing an important part in the innovation we are driving.”

Tessl Raises $125 Million to build AI Native Software Development

Nov 15, 2024

Team-GPT Raises $4.5Million to Discover and Deploy AI Use Cases in Enterprises

Nov 15, 2024

Ironclad Launches Jurist: an AI-Powered Assistant That Shows its Work

Nov 15, 2024

Prev Next 1 of 40,399

PervasID, backed by leading strategic investors such as Stanley Black & Decker, is the result of Dr Sabesan’s ground-breaking work as a PhD student at the University of Cambridge. His work in the area of battery-free RFID tag tracking has been internationally recognised and has resulted in four patents. As founder and CEO, Dr Sabesan successfully grew PervasID from its inception to become a global enterprise, providing transformative solutions to healthcare, industrial, security, retail and supply chain and logistics sectors with a complete product suite of the world’s most accurate passive RFID readers.

RFID systems use electromagnetic fields to automatically identify and wirelessly track tags which are attached to assets. Battery-free RFID tags contain electronically stored information and can be linked up as components of intelligent networks, with sensors to determine their location from a distance. RFID tags conventionally suffer from ‘dead spots’ where tags are not detected well within the range of the reader. PervasID overcomes this problem and achieves near 100% accuracy in detecting battery-free tags to less than one metre over wide areas. In commercial trials against all other competitors, PervasID achieved more than 99% tag detection accuracy over a 20-metre distance compared with 80% achieved over 2-metre to 3-metre distance using conventional approaches.

PervasID’s customers include the largest aircraft manufacturers, Stanley Black & Decker, blue chip retailers and NHS hospitals including Guy’s and St Thomas’ in London. Stanley Black & Decker also use the tags to track supplies from their tool cabinets used by aircraft manufacturers. Each cabinet contains over 1,000 tools, and it can result in serious safety incidents if any are left inside an aircraft. It is estimated that Foreign Object Debris (FOD) costs the aviation industry $13 Billion per year in direct and indirect costs, including flight delays, plane changes and fuel inefficiencies. In healthcare, PervasID solutions are being deployed in NHS hospitals for tracking surgical instruments to enhance decontamination and sterilisation processes and for tracking hospital assets to ensure that mission critical medical devices are available at the right place and time, for robust and efficient care. The need for this level of traceability of medical devices has been particularly evident in the COVID-19 pandemic. The solution is predicted to save £billions for NHS hospitals and will save lives.